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TheArthritis ResearchUKRheumatoid Arthritis Pathogenesis Centre of
Excellence (RACE) is a partnership between researchers at Newcastle
University, the University of Birmingham and the University of
Glasgow. Established in 2013, it is funded for 5 years, with a grant of
£2.5million fromArthritis ResearchUK and a further £4million pledged
by the three universities.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune
condition that affects the joints and internal organs. Synovial inflamma-
tion can cause cartilage and bone damage with resultant joint destruction
and associated disability. RACE aims to identify biological mechanisms
involved in the initiation of RA and its progression to a chronic disease,
and to identify novel therapeutic targets for control and cure.
It has long been recognized that patients' experience complements
researchers' skills (Hewlett et al., 2006). At the outset of the RACErch UK Rheumatoid Arthritis
wileyonlinelibrary.com/journal/project, it was agreed that patient engagement and involvement was
crucial to facilitate the translation of research undertaken by the centre
into public benefit. The present paper reports on a conference held at
the University of Birmingham in January 2016 to bring together patient
and public involvement (PPI) representatives from each hub, and to
provide patients' and carers' perspectives on the following questions:
• What should research charities focus their spending on?
• How can people with RA influence the research agenda?
• What are the best ways for scientists to feed back to patients,
relatives and carers about research findings?2 | BACKGROUND
PPI in all stages of the research process is advocated by funding bodies
and policy makers as a way of enhancing the relevance, quality andCopyright © 2016 John Wiley & Sons, Ltd.msc 1
2 POLLOCK ET AL.efficiency of research (INVOLVE, 2012; National Institute for Health
Research, 2015). The input of PPI partners has been shown to enhance
the design of clinical trials (Brett et al., 2014), development of patient‐
relevant research ideas (Bergsten et al., 2014), agenda setting (De Wit,
Abma, Koelewijn‐van Loon, Collins, & Kirwan, 2013) and developing
appropriate patient‐reported outcomes for clinical trials (de Wit, Kvien,
& Gossec, 2015). Evidence suggests that patients identify different
treatment priorities to clinicians (da Silva et al., 2010; Kwoh & Ibrahim,
2001). This reinforces the case for involving patients in the design of
research to ensure that their priorities are addressed, and to improve
the quality and impact of that research.
Patients have been involved in rheumatology research at each of
the three hubs prior to the inception of RACE; therefore, the project
offers a unique opportunity to bring together patient partners from
each of the hubs, to share experiences and best practice. Details of
these groups can be found in Table 1.3 | RACE PATIENT CONFERENCE
The conference was attended by two patient research partners from Bir-
mingham, five from Glasgow and six from Newcastle, 11 of whom com-
pleted a questionnaire prior to the conference, to describe their existing
experience of research involvement. The participants' previous involve-
ment in research activities is summarized in Tables 2 and 3. PatientTABLE 1 Patient involvement in rheumatology research
Birmingham The Birmingham Rheumatology Research Patient Partnership (
between people with rheumatoid arthritis and/or Sjögren's s
Birmingham, Sandwell, and West Birmingham Hospitals NH
It was officially launched in October 2014, building on the s
individual research projects.
Members of R2P2 are actively involved in all aspects of the
design of study procedures and of participant‐facing researc
dissemination of research findings via patient networks and s
related to the development of international research recomm
(Stack et al., 2015) and patient‐initiated research to determi
(Tiwana, Rowland, Fincher, Raza, & Stack, 2015).
Glasgow The Glasgow Patient Involvement in Rheumatology Research (
representation on clinical trial steering groups and further rec
patient partners has been through the National Rheumatoid
informal patient involvement for a number of years, while re
group (which includes patient representatives) of the Rheum
Newcastle
upon Tyne
The Newcastle Public Involvement in Musculoskeletal Services
project between Newcastle University and the Newcastle u
• To involve service users and carers in improving the qualit
individuals who use them
• To involve service users and carers in different aspects of
Trust, providing a forum for researchers and the public/pa
Researchers also discuss future projects and feed back results
Association (NESSA) and the local NRAS group.
TABLE 2 Frequency of patient research partners' previous experience of
Activity Neve
Developing grant application 9
Offering advice as a member of a project steering group 9
Developing research materials (e.g. patient information sheets) 9
Writing of research reports 10partners who attended the conference had limited previous research
involvement but were enthusiastic to become involved, as evidenced
by their attendance and comments at the conference.
Respondents were asked to describe any benefits they had expe-
rienced or anticipated from involvement in research. Similar responses
were obtained from those who had previous experience of PPI and
those who had none. These can be summarized as:
• A better understanding of current research
• An increased knowledge of the disease and how to alleviate symptoms
• An opportunity to support research and ensure that it is targeted
at patient needs
• Improved dissemination among patient groups
• Access to the latest research
Respondents were also asked to describe any difficulties they had
experienced or anticipated from PPI in research. Many had encoun-
tered or anticipated no difficulties, although some raised concerns
about the time commitment required, the use of technical language
or the possibility that deterioration in their health might result in them
withdrawing or reducing their involvement.
Clinicians and researchers from each hub were also present, along
with the RACE project manager and a representative from Arthritis
Research UK. Following an introductory presentation on PPI and theR2P2; http://www.bham.ac.uk/r2p2) is an established partnership
yndrome and rheumatology researchers at the University of
S Trust and University Hospitals Birmingham NHS Foundation Trust.
uccess of patient partner panels that had been established to support
research process, including the development of grant applications; the
h materials; the development of informational resources; and the
upport groups. Patient partners are co‐authors on papers, including those
endations (Gerlag et al., 2012); the development of patient questionnaires
ne why people with symptoms of rheumatoid arthritis delay seeking help
PIRR) group is in the early stages of its development with patient
ruitment of patient research partners under way. Identification of possible
Arthritis Society (NRAS), Arthritis Care and clinicians. There has been
search is a standing item on the agenda of the Patient Engagement sub‐
atology Managed Clinical Network of NHS Greater Glasgow and Clyde.
(PIMS) Group held its first formal meeting in March 2015. This joint
pon Tyne Hospitals NHS Foundation Trust has two main objectives:
y of services and making services more responsive to the needs of the
research projects at Newcastle upon Tyne Hospitals NHS Foundation
tient community to formally engage with each other
to existing patient groups, including the North East Sjögren's Syndrome
involvement in research projects
r
1 research
project
2–5 research
projects
More than 5 research
projects
1 1 0
0 1 1
0 2 0
0 1 0
TABLE 3 Frequency of patient research partners' previous experience
of involvement in research events
Events Never
1
event
2–5
events
More than
5 events
Setting research priorities 10 1 0 0
Sharing research findings
with the general public
9 0 2 0
POLLOCK ET AL. 3existing contribution of patient partners to rheumatology research at each
hub, delegates split into groups to facilitate discussion and debate of the
main topic areas. A third group of scientific researchers and clinicians affil-
iated with the University of Birmingham met separately to discuss the
same questions. The three groups were then brought together to share
key discussion points, which are summarized below, under each topic.4 | OUTCOMES FROM GROUP
DISCUSSIONS
4.1 | What should research charities focus their
spending on?
There were some key differences between the views expressed by
patient representatives and the expectations of researchers and clini-
cians. The latter group felt that patients would wish resources to be
directed towards development of new treatments, particularly for those
with longstanding, difficult‐to‐treat RA, who are increasingly described
as becoming a neglected group, in terms of research priorities.
However, patient representatives were of the opinion that research
to identify and evaluate new treatments for RA would be driven by the
pharmaceutical industry, and that charity funding should be focused on
understanding the biological processes that cause disease and on
predicting response to treatment. Other priorities for patients included:
• Evaluation of the effectiveness of self‐management strategies
• Development of treatments for RA‐related fatigue
• The development of educational and awareness‐raising initiatives
about RA.
The researchers/clinicians anticipated that patients' priorities
would feature research into the effectiveness of non‐pharmacological
approaches for the management of RA. The patient group agreed that
there was a need for evidence of the effectiveness of such approaches.
Patient representatives also reported that a focus on the therapeutic
effectiveness of treatments was more desirable than a focus on their
cost‐effectiveness.FIGURE 1 Ways in which people can be involved in the research cycle
(INVOLVE, 2012)4.2 | How can people with RA influence the research
agenda?
The importance of PPI in research, and research agenda setting, was
agreed by all three discussion groups. The challenges of involving
patients in basic laboratory‐based research were also discussed, with
particular reference to the language gap between patients andresearchers. Examples of successful approaches to this problem in pre-
vious projects were shared, such as the development of a glossary for
PPI partners taking part in the European Union's FP7 project
“EuroTEAM” (Towards Early diagnosis and biomarker validation in
Arthritis Management: www.team‐arthritis.eu). Many patient partners
perceived opportunities to become involved in research to be limited,
and reported a lack of public awareness of such opportunities, and of
the benefits of becoming involved. Benefits that were suggested
included the ability to access the latest research findings and to engage
with researchers, as well as the opportunity to “give something back”
for care received by contributing to the research process. It was sug-
gested that access to such benefits should be publicized and routinely
available to all patients.
A concern was raised by patients that those who become involved
with research may not be representative of the wider patient group,
and often develop extensive research expertise, leading to a possible
loss of perspective. It was agreed that it would be important to identify
ways to widen access to research involvement in order to mitigate this.
Patient representatives commented that it is not always straightfor-
ward for patients to attend research meetings in person, and opportu-
nities to learn about involvement and contribute to research in other
ways (e.g. via email or Skype) were welcomed.
The clinicians and researchers acknowledged the variety of oppor-
tunities for involving people throughout the research cycle (Figure 1),
and highlighted the responsibility of researchers to be aware of the ben-
efits of PPI, and to provide patients with comprehensive information
about current research and future possibilities in order for them to be
able to make fully informed suggestions and choices about research pri-
orities. It was suggested that, in this way, the research cycle (Figure 1)
should be seen as a virtuous cycle, where effective dissemination of
research findings to patients facilitates the input of patients to the
research agenda, and their ongoing engagement with the research pro-
cess. This was echoed by patient representatives, who suggested that
patient involvement should be an important aspect of training of
researchers, including those involved in basic, laboratory‐based science.
4 POLLOCK ET AL.4.3 | What are the best ways for scientists to feed
back to patients, relatives and carers about their
research findings?
All groups agreed that patients could usefully be involved in the devel-
opment and distribution of resources to communicate research find-
ings. Furthermore, it was felt that groups such the Birmingham
Rheumatology Research Patient Partnership (R2P2), the Glasgow
Patient Involvement in Rheumatology Research (PIRR) group and the
Newcastle Public Involvement in Musculoskeletal Services (PIMS)
group, or other patient‐organized groups were an important mecha-
nism for the dissemination of research findings.
It was suggested by patient representatives that it might be helpful
to conceptualize three tiers of target audience: patients already actively
engaged with research; patients who are not engaged; and the wider
public. Thus, dissemination to local groups who can then cascade infor-
mation via existing networks was perceived to be a useful approach.
There was a strong consensus that this type of dissemination activity
needed to occur at regular intervals, with a well‐publicized timetable.
Patient representatives involved in local groups suggested that they
would value a database of local researchers who were willing to present
their work to patients, along with opportunities to link with websites or
mail‐outs associated with other local and national patient groups. While
the importance of increased opportunities for social networking in this
context was discussed, patient representatives felt that traditional
media should not be neglected, as many patients do not use the internet
or social media. Several patients suggested that patient‐friendly posters
displayed in outpatient settings could be an effective route for local dis-
semination. In the researchers' group, there was discussion about
whether clinicians or scientists were best placed to disseminate research
findings to patients. Some concern was expressed by non‐clinical
researchers that therewould be a perception on the part of patients that
all researchers would have clinical knowledge. However, several non‐
clinical researchers described very positive experiences of face‐to‐face
dissemination to patient groups, although it was acknowledged that pre-
paratoryworkwas necessary to ensure appropriate use of non‐technical
language and management of patients' expectations in relation to the
researcher's ability to answer clinical questions.
Patient representatives stressed the importance of communicating
with patient partners throughout the research cycle, as well as on com-
pletion of specific research projects, and highlighted the need for train-
ing for researchers from an early stage of their career, to provide them
with skills in the communication of research findings to patients and
the wider public.
It was suggested that university press offices could be better
engaged with scientists, and that there was a potentially useful role
for patients to be involved in the identification of tractable items aris-
ing from research findings that might be seen as newsworthy.5 | CONCLUSIONS
In summary, there was wide agreement about the benefits of PPI in
rheumatology research for all stakeholders. It was also generally
agreed that research into the basic disease mechanisms of RA andprediction of disease outcome should be important priorities, although
scientists/clinicians had expected patients to place greater emphasis
on the development of new treatments and non‐pharmacological
approaches. Participants shared their experiences of dissemination
activities and identified effective strategies and opportunities for
patient involvement in this context. An important role for patient
groups and networks was identified in this context. We acknowledge
that participating patients had previously expressed an interest in
involvement with the RACE project, and their views may not represent
those of all patients with RA. Further research is necessary to ascertain
variations in patient perspectives in this context.
The RACE patient conference has identified key issues that should
be addressed to facilitate patient involvement in rheumatology research:
• Increasing awareness of PPI and involvement opportunities
• Widening access to research involvement
• Increasing involvement of patients in research priority setting
• Training for researchers on the benefits of PPI and identification of
involvement opportunities
• Training for researchers in the communication of research findings
to patients
• Improving communication between researchers and patient
groups
• Fostering robust networks for communication between
researchers, patient groups, uninvolved patients and the wider
public
• Increasing opportunities for sharing best practice in patient
involvement and the dissemination of research findings to
patients, carers, relatives and the wider public.ACKNOWLEDGEMENTS
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